FATE THERAPEUTICS INC
Profile
Company Names
FATE THERAPEUTICS INC
Addresses
3535 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO, CA 92121
10931 NORTH TORREY PINES ROAD, SUITE107, LA JOLLA, CA 92037
Phone Numbers
858.875.1803
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2007
State Incorporated:
DELAWARE
Total Amount Raised:
$241,273,040.00
Number of Funding Rounds:
9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2020-06-24
$49,999,989.00
$49,999,989.00
$0.00
Equity
8
2020-04-07
$50,000,024.00
$50,000,024.00
$0.00
Equity
7
2016-11-23
$56,749,988.00
$56,749,988.00
$0.00
Equity
6
2016-08-09
$10,290,000.00
$10,290,000.00
$0.00
Equity
5
2015-05-07
$8,000,000.00
$8,000,000.00
$0.00
Equity
4
2013-08-08
$20,000,000.00
$20,000,000.00
$0.00
Debt
3
2012-05-04
$9,244,679.00
INDEFINITE
INDEFINITE
Equity
2
2011-03-30
$1,000,000.00
$1,000,000.00
$0.00
Debt
1
2009-11-10
$35,988,360.00
$35,988,360.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT
EPSTEIN
DIRECTOR
PCM PROVIDENT AGENCY FUND LTD
| PCM PROVIDENT AGENCY FUND LP
| COTA RACING + ENTERTAINMENT LLC
| PCM PROVIDENT MBS FUND LP
| PCM PROVIDENT MBS FUND LTD.
| 2100 FREEDOM, INC.
| PROTEUS DIGITAL HEALTH, INC.
| ATX SOCCER LLC
| FATE THERAPEUTICS INC
| MINDSTRONG, INC.
| PROPHET CAPITAL REIT INC.
| PROPHET ADVANTAGE PARTNERS LP
| ROLLZI LLC
| COTA EMERALD CITY FUND LP
| PROSCIA INC.
| MEDMO, INC.
| COVERA HEALTH, INC.
PAUL
GRAYSON
EXECUTIVE OFFICER, DIRECTOR
ROBERT
HERSHBERG
DIRECTOR
MICHAEL
LEE
DIRECTOR
AMPCI MACQUARIE INFRASTRUCTURE MANAGEMENT NO. 1 LTD
| NEXTPAGE INC
| CAMSTAR SYSTEMS INC
| AIRCLIC INC
| NEXTPAGE, INC.
| CLARET MEDICAL, INC.
| AMPCI MACQUARIE INFRASTRUCTURE MANAGEMENT NO 1 LIMITED, AMPCI MACQUARIE INFRASTRUCTURE MANAGEMENT NO 2 LIMITED, + DUET INVESTMENT HOLDINGS LTD
| ORIENT BANCORPORATION
| ZOOVE CORP
| WATCHWITH, INC.
| MYFITNESSPAL, INC.
| SECUREKEY TECHNOLOGIES INC.
| PINGPLOT, INC.
| SBT REIT, INC.
| MY-NYOOBE, INC
| FATE THERAPEUTICS INC
| EXO-TOE, LLC
| ATOMIC FI, INC.
| MGL FUND, LLC
| FIVE STAR BANCORP
| IGM BIOSCIENCES, INC.
| CARL MARKS STRATEGIC OPPORTUNITIES FUND IV, L.P.
JOHN
MENDLEIN
EXECUTIVE OFFICER, DIRECTOR
AMIR
NASHAT
DIRECTOR
PROMEDIOR INC
| AVILA THERAPEUTICS INC
| PERVASIS THERAPEUTICS INC
| FATE THERAPEUTICS INC
| BIND BIOSCIENCES INC
| SELECTA BIOSCIENCES INC
| POLARIS VENTURE PARTNERS VI, L.P.
| SUN CATALYTIX CORP
| RECEPTOS, INC.
| POLARIS ENTREPRENEURS- FUND VII, L.P.
| POLARIS PARTNERS VII, L.P.
| ATYR PHARMA INC
| AGBIOME, LLC
| METACRINE, INC.
| SCHOLAR ROCK LLC
| 1366 TECHNOLOGIES INC
| SOFREGEN MEDICAL INC.
| POLARIS ENTREPRENEURS- FUND VIII, L.P.
| SYROS PHARMACEUTICALS, INC.
| SCHOLAR ROCK HOLDING CORP
| CAMP4 THERAPEUTICS CORP
| MORPHIC HOLDING, LLC
| FREENOME HOLDINGS, INC.
| PRIMMUNE THERAPEUTICS, INC.
| MORPHIC HOLDING, INC.
ROBERT
NELSEN
DIRECTOR
FORGE INC
| RECEPTOS, INC. (F.K.A. RECEPTOR PHARMACEUTICALS INC.)
| AGIOS PHARMACEUTICALS INC
| KILIMANJARO ENERGY, INC.
| NEUROGESX INC
| KYTHERA BIOPHARMACEUTICALS INC
| SYROS PHARMACEUTICALS, INC.
| FATE THERAPEUTICS INC
| CENEXYS, INC.
| JUNO THERAPEUTICS, INC.
| BELLEROPHON THERAPEUTICS LLC
| FARADAY PHARMACEUTICALS, INC.
| SAPPHIRE ENERGY, INC.
| UNITY BIOTECHNOLOGY, INC.
| ARIVALE INC.
| SIENNA BIOPHARMACEUTICALS, INC.
| GOSSAMER BIO, INC.
| VIR BIOTECHNOLOGY, INC.
| BEAM THERAPEUTICS INC.
| GRAIL, INC.
| APEX NEURO HOLDINGS, INC.
| NUTCRACKER THERAPEUTICS, INC.
| SANA BIOTECHNOLOGY, INC.
| INSITRO, INC.
| NATIONAL RESILIENCE, INC.
| MEDICAL CREATIONS, INC.
| NEUMORA THERAPEUTICS, INC.
| RIPPL CARE, INC.
| SEAPORT THERAPEUTICS, INC.
ROBERT
T.
NELSEN
DIRECTOR
WILLIAM
RASTETTER
EXECUTIVE OFFICER, DIRECTOR
BRYAN
ROBERTS
DIRECTOR
VITAE PHARMACEUTICALS, INC
| VENTANA HEALTH SERVICES, INC.
| INTARCIA THERAPEUTICS, INC
| CASTLIGHT HEALTH, INC.
| TANDEM TECHNOLOGIES, INC.
| SURFACE LOGIX INC
| POWERVISION, INC.
| CODERYTE INC
| KYRUUS, INC.
| ARIA DIAGNOSTICS, INC.
| ACHAOGEN INC
| FATE THERAPEUTICS INC
| ADVANCE MEDICAL, LTD.
| BELLEROPHON THERAPEUTICS LLC
| MUSE BIOTECHNOLOGY, INC.
| STRIDE HEALTH, INC.
| DEVOTED HEALTH, INC.
| INSCRIPTA, INC.
| LYRA HEALTH, INC.
| PSY THERAPEUTICS, INC.
| MYTHIC THERAPEUTICS, INC.
| SITKA, INC./DELAWARE
| PUBLIC HEALTH CO GROUP, INC.
| GRAND ROUNDS, INC.
| SMITH HEALTH, INC.
| KELONIA THERAPEUTICS, INC.
| JW CELTICS INVESTMENT CORP.
| ACCOMPANY HEALTH, INC.
BRYAN
E.
ROBERTS
DIRECTOR
CERULEAN PHARMA INC.
| IRONWOOD PHARMACEUTICALS INC
| IKARIA HOLDINGS INC
| FATE THERAPEUTICS INC
| ACHAOGEN INC
| VENROCK ASSOCIATES VI, L.P.
| VENROCK PARTNERS VI, L.P.
| VENROCK ASSOCIATES VII, L.P.
| VENROCK ASSOCIATES VIII, L.P.
| VENROCK ASSOCIATES IX, L.P.
| VENROCK ASSOCIATES X, L.P.
| VENROCK PARTNERS X, L.P.
CARL
WEISSMAN
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2020-06-24
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2020-04-07
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2016-11-23
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2016-08-09
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2015-05-07
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Debt
2013-08-08
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
